ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,767Medicare Part D Prescriptions Filled, Including Refills

Rank: 78 out of 917

$489K Total Retail Price of All Prescriptions

Rank: 127 out of 917

438 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
28% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Washington
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 438 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

12% of this provider’s 438 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 10,162 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Washington
SIMVASTATIN 814 758 1 2
LISINOPRIL 488 456 2 1
LEVOTHYROXINE SODIUM 439 433 3 3
AMLODIPINE BESYLATE 425 412 4 5
OMEPRAZOLE 372 352 5 4
METOPROLOL TARTRATE 353 313 6 11
METFORMIN HCL 349 323 7 8
HYDROCHLOROTHIAZIDE 301 294 8 9
FUROSEMIDE 241 231 9 7
WARFARIN SODIUM 220 193 10 10
CITALOPRAM HBR 199 199 11 15
GABAPENTIN 176 176 12 17
HYDROCODONE-ACETAMINOPHEN 163 141 S3 13 6
SERTRALINE HCL 158 149 14 24
DONEPEZIL HCL 141 141 15 32
BENICAR 134 121 16 104
METOPROLOL SUCCINATE 125 125 17 18
CARVEDILOL 113 110 18 33
ALENDRONATE SODIUM 107 105 19 23
FLUTICASONE PROPIONATE 106 105 20 26
RANITIDINE HCL 100 96 21 29
TAMSULOSIN HCL 93 93 22 25
ALLOPURINOL 84 64 23 31
CRESTOR 81 81 24 30
POTASSIUM CHLORIDE 81 81 24 16
LANTUS 80 60 26 37
LOSARTAN POTASSIUM 78 73 27 13
ATORVASTATIN CALCIUM 75 75 28 14
OXYCODONE-ACETAMINOPHEN 73 68 S2 29 46
TRAMADOL HCL 72 70 30 28
SPIRIVA 69 67 31 45
CLOPIDOGREL 63 63 32 50
PRAVASTATIN SODIUM 63 63 32 20
HYDRALAZINE HCL 63 63 32 90
FENTANYL 63 63 S2 32 58
SULFAMETHOXAZOLE-TRIMETHOPRIM 60 53 36 116
TRIAMTERENE-HCTZ 56 56 37 36
RISPERIDONE 56 49 37 51
FINASTERIDE 55 55 39 77
NAMENDA 53 53 40 43
PREDNISONE 53 46 40 34
MIRTAZAPINE 52 51 42 39
OXYCODONE HCL 51 49 S2 43 27
VERAPAMIL ER 51 51 43 145
GLIPIZIDE 51 50 43 40
PLAVIX 50 50 46 84
OXYBUTYNIN CHLORIDE 50 44 46 76
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 11, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.